August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Excellence in Oncology Care Shares 5-Year KN564 Data on Adjuvant Pembrolizumab in RCC
Jun 2, 2025, 09:18

Excellence in Oncology Care Shares 5-Year KN564 Data on Adjuvant Pembrolizumab in RCC

Excellence in Oncology Care – EIOC posted on X:

“5 year follow up for adjuvant pembro in RCC (KN564). DFS (5yr 52% v61% – HR0.71). OS (5yr 82% vs 88% HR0.66). Maintained KM curve separation.”

Excellence in Oncology Care Shares 5-Year KN564 Data on Adjuvant Pembrolizumab in RCC

More posts featuring ASCO25.